Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 

MedChemExpress

  Alle Produkte
 
Website: 
http://www.medchemexpress.com
 
SARS-CoV-2 - Deferoxamin - Therapeutika-Kandidaten

SARS-CoV-2 - Deferoxamin - Therapeutika-Kandidaten

Ergebnis Ihrer Suche : 11 Produkt(e) gefunden

Grenzen Sie Ihre Suche ein :

RUOCE / IVD
  • Unconjugated 2
  • Biochemicals 8
  • Inhibitor/Antagonist/Agonist 3
FILTER ANWENDEN
REINITIALISIEREN


Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
HY-B0988-100mg
Deferoxamine (mesylate) [138-14-7]
 100mg 
HY-B1625-5mg
Deferoxamine [70-51-9]
 5mg 
HY-B1625-1mg
Deferoxamine [70-51-9]
 1mg 
HY-B1625-10mg
Deferoxamine [70-51-9]
 10mg 
HY-B1625-1ml
Deferoxamine [70-51-9]
 10mM/1mL 
HY-B0988-20mg
Deferoxamine (mesylate) [138-14-7]
 20mg 
HY-B0988-500mg
Deferoxamine (mesylate) [138-14-7]
 500mg 
HY-132989-25mg
Mal-Deferoxamine [1638156-31-6]
 25mg 
HY-132989-50mg
Mal-Deferoxamine [1638156-31-6]
 50mg 
HY-134797-5mg
p-SCN-Bn-deferoxamine [1222468-90-7]
 5mg 
HY-134797-10mg
p-SCN-Bn-deferoxamine [1222468-90-7]
 10mg 
    ‹
    ›